A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).

@article{OBrien2007ACA,
  title={A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).},
  author={Sarah H O'Brien and Arthur Kim Ritchey and Kenneth J. Smith},
  journal={Pediatric blood & cancer},
  year={2007},
  volume={48 2},
  pages={173-80}
}
BACKGROUND The primary objective in the treatment of acute pediatric idiopathic thrombocytopenic purpura (ITP) is to rapidly increase the platelet count. METHODS We built a decision analytic model to evaluate the cost-utility of four commonly used treatment strategies: intravenous immunoglobulin G (IVIG) 0.8 g/kg, anti-D 75 mcg/kg, methylprednisolone (30 mg/kg for 3 days), and prednisone (4 mg/kg/day for 4 days). In our baseline model, all children were hospitalized upon presentation, and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…